Dr. Dirk Pamperin

Dr. Dirk Pamperin is an experienced pharmaceutical executive currently serving as CEO of Rocketlane Medical Ventures GmbH since January 2023. With a robust background in research and development, Dr. Pamperin has been the General Manager at APOGEPHA Arzneimittel GmbH since June 2012, where Dr. Dirk also held the roles of Director Research & Development and Chief Scientific Officer. Additionally, Dr. Pamperin has been a Member of the Advisory Board for Synthaverse since February 2018. Prior experience includes serving as Vice President of Research and Development at Synthon from October 2005 to June 2012, and as Head of Project Management/R&D Coordination at Apogepha Arzneimittel GmbH from May 1998 to September 2005. Dr. Pamperin earned a PhD in Chemistry/Biotechnology from TU Braunscheig and Universität Stuttgart between 1987 and 1998.